Thoraco-Lumbar Fascia Mobility (TLFM)

May 3, 2021 updated by: Palmer College of Chiropractic

Thoraco-Lumbar Fascia Mobility in Persons With Chronic Low Back Pain

The purpose of the Thoraco-Lumbar Fascial Mobility (TLFM) study is to use ultrasound to measure the movement of connective tissue in the low back area of individuals with chronic low back pain (lasting more than 1 year). This study will compare baseline measurements, measurements after a single high velocity low amplitude spinal manipulation (HVLA-SM) and after a course of up to 16 HVLA-SM.

Study Overview

Status

Completed

Conditions

Detailed Description

The investigators will conduct a single arm pilot (proof-of-concept) clinical trial. Approximately 30 participants with self-reported chronic low-back pain (LBP), defined as pain for ≥ 1-year in duration and pain on at least ½ of the days in the past 6-months, will be enrolled.

This trial will consist of two separate enrollment phases. Phase 1 consists of enrollment at baseline followed by 3 separate ultrasound measurements. Phase 1 ends after a 4-week no treatment run-in phase.

Phase 2 begins twice-weekly HVLA-SM treatments to the thoracolumbar region for 8-weeks. Two ultrasound imaging evaluations will occur at visit 1 (pre and post-treatment). Pre-treatment ultrasound evaluations will be obtained at 4-weeks and 8-weeks.

The primary outcome is shear strain (adjacent tissue layer mobility measured with ultrasound) at the level of the lumbar L2-L3 vertebrae bilaterally. Ultrasound measures will be obtained with a Terason t3000 system using a 12L5 linear array probe with 10 MHz setting. Because shear strain may differ between sexes, we will attempt to recruit equal numbers of male and female participants.

Study Type

Interventional

Enrollment (Actual)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Iowa
      • Davenport, Iowa, United States, 52803
        • Palmer Center for Chiropractic Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion:

  1. Adults between 21 and 65 years
  2. LBP of ≥ 1-yr duration with at least ½ of days with pain over the prior 6-months
  3. Able to understand study procedures and willing to sign informed consent document
  4. Willing to forgo any manual therapy for LBP for the initial 4-week study period
  5. Willing to forgo any manual therapy for LBP other than study treatments during the 8-week treatment period
  6. Able to tolerate and safely receive study procedures

Exclusion Criteria:

  1. Chiropractic care or other manual therapy for at least 90 days prior to baseline visit
  2. Unable to visualize necessary tissue layers using musculoskeletal ultrasound
  3. Weight above 350 lbs
  4. Unable to tolerate or safely receive study procedures
  5. Need for referral
  6. Unable or unwilling to comply with study procedures
  7. Current or planned pregnancy (self-reported) within the study timeframe
  8. Any prior surgery to the thoracolumbar region
  9. Needing a proxy
  10. Connective tissue disorder such as Marfan and Ehlers-Danlos syndrome

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: single study arm
All enrolled participants will undergo ultrasound evaluation and chiropractic low back spinal manipulation treatment.
HVLA-SM is a commonly used spinal manipulation treatment for patients with chronic low back pain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Examine changes in thoracolumbar fascia movement (called shear-strain) using ultrasound
Time Frame: Short term change (Baseline), longer-term change (4 weeks)
Short and longer-term changes in shear-strain will be studied by comparing between ultrasound recordings obtained at baseline and between measurements obtained at baseline and after 4-weeks
Short term change (Baseline), longer-term change (4 weeks)
Investigate changes in thoracolumbar fascia movement (called shear-strain) using ultrasound after high-velocity low-amplitude spinal manipulation
Time Frame: 4-weeks, 8-weeks, 12 weeks
Changes in shear-strain measures associated with high-velocity low-amplitude spinal manipulation will be assessed at 3 separate time points.
4-weeks, 8-weeks, 12 weeks
Examine differences in thoracolumbar movement (called shear-strain) using ultrasound. Measurements will be obtained in relaxed and active muscle contraction states
Time Frame: Baseline
Compare thoracolumbar shear strain during relaxed passive flexion with active paraspinal contraction during passive flexion.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Reported Outcomes Measurement Information System (PROMIS) Global Health questions on pain intensity
Time Frame: Baseline, 4 weeks, 8 weeks, and 12 weeks
Worst, average, and current pain intensity measured on a self-reported 5-point numerical rating scale. Lower scores indicate lower pain
Baseline, 4 weeks, 8 weeks, and 12 weeks
Patient Reported Outcomes Measurement Information System (PROMIS) Global Health questions of pain interference
Time Frame: Baseline, 4 weeks, 8 weeks, and 12 weeks
Pain interference measured on a self-reported 4-point numerical rating scale. The scale ranges from 4-20. Lower scores indicate higher pain interference.
Baseline, 4 weeks, 8 weeks, and 12 weeks
Roland Morris Disability Questionnaire (RMDQ)
Time Frame: Baseline, 4 weeks, 8 weeks, and 12 weeks
A 24-item self-reported scale assessing low-back pain related disability. Scores range from 0-24 with higher scores indicating higher disability.
Baseline, 4 weeks, 8 weeks, and 12 weeks
Patient Reported Outcomes Measurement Information System (PROMIS) nociceptive pain quality scale
Time Frame: Baseline
A 5-item self-reported scale used to identify persons more likely to have nociceptive pain. The scale ranges from 5-25 with higher scores indicating nociceptive pain is more likely.
Baseline
Perceived Global Low Back Pain Improvement
Time Frame: 12 weeks
A single question asking patients about their perceived improvement on a 7 point scale. Lower scores indicate greater improvement.
12 weeks
Patient Reported Outcomes Measurement Information System (PROMIS) neuropathic pain quality scale
Time Frame: Baseline
A 5-item self-reported scale used to identify persons more likely to have neuropathic pain. The scale ranges from 5-25 with higher scores indicating neuropathic pain is more likely.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Robert Vinining, DC, DHSc, Palmer College of Chiropractic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 9, 2019

Primary Completion (Actual)

April 30, 2021

Study Completion (Actual)

April 30, 2021

Study Registration Dates

First Submitted

April 8, 2019

First Submitted That Met QC Criteria

April 12, 2019

First Posted (Actual)

April 16, 2019

Study Record Updates

Last Update Posted (Actual)

May 4, 2021

Last Update Submitted That Met QC Criteria

May 3, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TLFM

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

This is a proof of concept study. No data will be available for sharing.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on High Velocity Low amplitude spinal manipulation (HVLA-SM)

3
Subscribe